Current smokers develop more posterior myocardial infarctions probably due to increased tendency to thrombosis

Scandinavian Cardiovascular Journal

Volumn 34, Issue 1, 2000, Pages 73-78

  Landmark, Knud ^a,b   Abdelnoor, Michael ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Age; Infarct size and localization; Male patients; Smoking; Thrombosis

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; Q WAVE; RISK ASSESSMENT; SMOKING; THROMBOSIS;

EID: 0034044972     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017430050142431     Document Type: Article

References (39)

1. Vriz O, Nesbitt S, Krause L, Majahalme S, Lu H, Julius S. Smoking is associated with higher cardiovascular risk in young women than in men: The Tecumseh Blood Pressure Study. J Hypertens 1997; 15: 127-134.
2. Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. Br Med J 1998; 316: 1043-1047.
3. Mølstad P. First myocardial infarction in smokers. Eur Heart J 1991; 12: 753-759.
4. Gottlieb S, Boyka V, Zahger D, et al., for the Israeli Thrombolytic Survey Group. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey). J Am Coll Cardiol 1996; 28: 1506-1513.
5. Barbash GI, White HD, Modan M, et al., for the Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation 1993; 87: 53-58.
6. Bourke S, Conroy RM, Mulcahy R, Robinson K. Aetiological and prognostic correlates of site of myocardial infarction. Eur Heart J 1988; 9: 734-739.
7. Gomez MA, Karagounis LA, Allen A, Anderson JL, for the TEAM-2 investigators. Effect of cigarette smoking on coronary patency alter thrombolytic therapy for myocardial infarction. Am J Cardiol 1993; 72: 373-378.
8. Grines CL, Topol EJ, O'Neill WW, et al. Effects of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 1995; 91: 298-303.
9. White HD. Lifting the smoke-screen: the enigma of better outcome in smokers after myocardial infarction. Am J Cardiol 1995; 75: 278-279.
10. Hasdai D, Rihal CS, Lerman A, Grill DE, Holmes Jr DR. Smokers undergoing percutaneous coronary revascularization present with fewer narrowings in the target coronary artery. Am J Cardiol 1997; 80: 1211-1214.
11. Ishihara M, Sato H, Tateishi H, et al. Clinical implications of cigarette smoking in acute myocardial infarction: acute angiographic findings and long-term prognosis. Am Heart J 1997; 134: 955-960.
12. Bates ER, Califf RM, Stack RS, et al., and the Thrombolysis and Angioplasty in Myocardial Infarction Study Group. Thrombolysis and angiography in myocardial infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortality. J Am Coll Cardiol 1989; 13: 12-18.
13. Kleinbaum D, Kupper L, Morgenstern H. Epidemiologic Research. New York: Van Nostrand Reinhold, 1982.
14. Rumeau-Rouquette C, Bréart G, Padieu R Méthodes en Épidémiologie. Paris: Médecine-Sciences Flammarion, 1989.
15. Hennekens C, Buring J, Mayrent S. Epidemiology in medicine. Boston: Little-Brown, 1987.
16. Elwood JM. Causal relationships in medicine. A practical system for critical appraisal. Oxford. New York, Melbourne: Oxford University Press, 1992.
17. Hosmer Jr DW, Lemeskow S. Applied logistic regression. New York: Wiley & Sons, 1989.
18. Robinson K, Conroy RM, Mulcahy R. Smoking and acute coronary heart disease: a comparative study. Br Heart J 1988; 60: 465-469.
19. Nitenberg A, Antony I, Foult J-M. Acetylcholine-induced coronary vasoconstriction in young, heavy smokers with normal coronary angiographic findings. Am J Med 1993; 95: 71-77.
20. Quillen JE, Rossen JD, Oskarsson H, Minor Jr RL, Lopez AG, Winniford MD. Acute effects of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels. J Am Coll Cardiol 1993; 22: 642-647.
21. Moliterno DJ, Willard JE, Lange RA, et al. Coronaryartery vasoconstriction induced by cocaine, cigarette smoking, or both. N Engl J Med 1994; 330: 454-459.
22. Czernin J, Sun K, Brunken R, Böttcher M, Phelps M, Schelben H. Effect of acute and long-term smoking on myocardial blood flow and flow reserve. Circulation 1995; 91: 2891-2897.
23. Zeiher AM, Schächinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 1995; 92: 1094-1100.
24. Kugiyarna K, Yasue H, Ohgushi M, et al. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers. J Am Coll Cardiol 1996; 28: 1161-1167.
25. Lekakis J, Papamichael C, Vemmos C, et al. Effect of acute cigarette smoking on endothelium-dependent brachial artery dilatation in healthy individuals. Am J Cardiol 1997; 79: 529-531.
26. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characterics on clotting factors and the risk of ischaemic heart disease. Lancet 1987; ii: 986-988.
27. Kimura S, Nishinaga M, Ozawa T, Shimada K. Thrombin generation as an acute effect of cigarette smoking. Am Heart J 1994; 128: 7-11.
28. Hung J, Lam JYT, Lacoste L, Letchacovski G. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation 1995; 92: 2432-2436.
29. Burke AP, Farb A, Malcom GT, Liang Y-H, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336: 1276-1282.
30. Wennmalm Å, Benthin G, Granström EF, Persson L, Winell S. Maintained hyperexcretion of thromboxane A2 metabolite in healthy young cigarette smokers: results from a prospective study in randomly sampled males with stable smoking habits. Clin Physiol 1993; 13: 257-264.
31. Gleerup G, Winther K. Smoking further increases platelet activity in patients with mild hypertension. Eur J Clin Invest 1996; 26: 49-52.
32. Roald HE, Ørwim U, Bakken IJ, Barstad RM, Kierulf P, Sakariassen KS. Modulation of thrombotic responses in moderately stenosed arteries by cigarette smoking and aspirin ingestion. Arterioscler Thromb 1994; 14: 617-621.
33. Foults JD, Bonebrake FC. The effects of cigarette smoke and nicotine on platelet thrombus formation in stenosed dog coronary arteries: inhibition with phentolamine. Circulation 1982; 65: 465-470.
34. Mueller HS, Cohen LS, Braunwald E, et al., for the TIMI investigators. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction: analyses of patient subgroups in the thrombolysis in myocardial infarction (TIMI) trial, phase II. Circulation 1992; 85: 1254-1264.
35. Hasdai D, Lerman A, Charanjit SR, et al. Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction. Am Heart J 1999; 137: 612-620.
36. Col NF, Yarzebski J, Gore JM, Alpert JS, Goldberg RJ. Does aspirin consumption affect the presentation or severity of acute myocardial infarction? Arch Intern Med 1995; 155: 1386-1389.
37. Abdelnoor M, Landmark K. Infarct size is reduced and the frequency of non-Q-wave myocardial infarctions is increased in patients using aspirin at the onset of symptoms. Cardiology 1999; 91: 119-126.
38. Rivers JT, White HD, Cross DB, Williams BF, Norris RM. Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking. J Am Coll Cardiol 1990; 16: 340-348.
39. Karagounis L, Moreno F, Menlove RL, Ipsen S, Anderson JL, and the TEAM-2 investigators. Effects of early thrombolytic therapy (anistreplase versus streptokinase) on enzymatic and electrocardiographic infarct size in acute myocardial infarction. Am J Cardiol 1991; 68: 848-856.